HRTX News and Press, Heron Therapeutics Inc. From 07/28/23

2023-07-28 15:57:50 ET Summary HRTX recently launched a fourth drug, Aponvie, with the first full quarter of product sales to come with Q2'23 earnings. An upcoming potential expansion of the Zynrelef label could see the drug used in twice as many surgeries, improving product sales...

2023-07-26 08:28:03 ET Silicon Motion Technology  ( NASDAQ: SIMO ) +80% . PacWest Bancorp ( PACW ) +30% . Warrantee Inc. American Depositary  ( WRNT ) +24% . Tilray Brands ( TLRY ) +13% spikes as bottom line improves amid Q4 revenue ...

2023-07-24 13:08:14 ET Are you looking for the best penny stocks to buy now ? There are plenty to choose from, and how you approach the stock market today will help determine your strategy. Are you looking for stocks to day trade? Maybe you are more of a swing trader looking to ride out...

2023-07-24 09:28:20 ET Heron Therapeutics ( NASDAQ: HRTX ) rose ~5% Monday pre-market after the biotechnology company said that it has reduced its employees by ~25% as part of a cost reduction plan and corporate restructuring, and is launching an ~$30M private placeme...

Heron Therapeutics Announces Cost Reduction Plan and Restructuring PR Newswire - Expected overall cash savings of $75 million through 2025 - New executive management team in place SAN DIEGO , July 24, 2023 /PRNewswire/ -- Heron Therapeutics...

Heron Therapeutics Announces $30 Million Private Placement Financing PR Newswire SAN DIEGO , July 24, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing a...

2023-07-07 04:44:25 ET Summary Heron Therapeutics' stock has significantly declined over the past five years, with shares dropping from over $40 to under $1.20. Despite struggles, the company's recently approved product, ZYNRELEF, for postoperative pain management, could potential...

2023-06-23 16:12:49 ET Heron Therapeutics ( NASDAQ: HRTX ) said on Friday that it had appointed Ira Duarte as chief financial officer. HRTX shares up +1.6% in after hours trading. Duarte previously served as the CFO of Veloxis Pharmaceuticals. Press Release ...

Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer PR Newswire SAN DIEGO , June 23, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patien...

Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer PR Newswire SAN DIEGO , June 12, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the live...